OOIR: Observatory of International Research

Papers

(The H4-Index of British Journal of Pharmacology is 49. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Mas‐related G protein‐coupled receptors in gastrointestinal dysfunction and inflammatory bowel disease: A review	423
Dual action of macrophage miR‐204 confines cyclosporine A‐induced atherosclerosis	341
Influx of kynurenine into the brain is involved in the reduction of ethanol consumption induced by Ro 61‐8048 after chronic intermittent ethanol in mice	324
Issue Information	225
Animal models of diabetes‐associated vascular diseases: an update on available models and experimental analysis	203
Issue Information	179
	174
Integrating novel immunotherapeutic approaches in organ‐preserving therapies for bladder cancer	157
Issue Information	153
The respiratory depressant effects of mitragynine are limited by its conversion to 7‐OH mitragynine	147
P2X2 receptor subunit interfaces are missense variant hotspots, where mutations tend to increase apparent ATP affinity	128
	124
A new class of 5‐HT_2A/5‐HT_2C receptor inverse agonists: Synthesis, molecular modeling, in vitro and in vivo pharmacology of novel 2‐aminotetralins	118
Allosterism in the adenosine A_2A and cannabinoid CB₂ heteromer	115
Correction to “Melatonin epigenetic potential on testicular functions and fertility profile in varicocele rat model is mediated by silent information regulator 1”	110
Graph‐based algorithms to dissect long‐distance water‐mediated H‐bond networks for conformational couplings in GPCRs	107
Combined therapy with pirfenidone and nintedanib counteracts fibrotic silicosis in mice	105
Novel therapeutic approaches to target neurodegeneration	100
Identification of active ingredients from Lamiophlomis rotata that increase wound repair in mouse skin	96
Chemosensory signalling in human sperm is controlled by Ca²⁺ influx via CatSper and Ca²⁺ clearance via plasma membrane Ca²⁺ ATPases	94
Opportunities of patient‐derived organoids in drug development	92
	91
Structural and molecular determinants of mineralocorticoid receptor signalling	90
Epithelial deletion of the glucocorticoid receptor (Nr3c1) protects the mouse intestine against experimental inflammation	85
Deferiprone attenuates neuropathology and improves outcome following traumatic brain injury	83

Inhibition of HSP90 S‐nitrosylation alleviates cardiac fibrosis via TGFβ/SMAD3 signalling pathway	77
A small molecule CFTR potentiator restores ATP‐dependent channel gating to the cystic fibrosis mutant G551D‐CFTR	76
Gβγ subunit signalling underlies neuropeptide Y‐stimulated vasoconstriction in rat mesenteric and coronary arteries	70
Is platelet responsiveness to clopidogrel attenuated in overweight or obese patients and why? A reverse translational study in mice	69
Pharmacokinetics and cardioprotective efficacy of intravenous miR‐125b* microRNA mimic in a mouse model of acute myocardial infarction	69
Role of Na_V1.7 in action potential conduction along human bronchial vagal afferent C‐fibres	69
GPR84 in physiology—Many functions in many tissues	68
Chronic stress induces behavioural changes through increased kynurenic acid by downregulation of kynurenine‐3‐monooxygenase with microglial decline	68
Scorpion venom heat‐resistant synthesized peptide ameliorates 6‐OHDA‐induced neurotoxicity and neuroinflammation: likely role of Na_v1.6 inhibition in microglia	67
Palbociclib blocks neutrophilic phosphatidylinositol 3‐kinase activity to alleviate psoriasiform dermatitis	66
Exploring pharmacological inhibition of G_q/11 as an analgesic strategy	65
Quantitative prediction of P‐glycoprotein‐mediated drug–drug interactions and intestinal absorption using humanized mice	65
Supersulfide biology and translational medicine for disease control	62
Exploring group size for statistical analysis of real‐time signalling experiments	59
Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity	59
Issue Information	58
β‐Arrestin‐biased proteinase‐activated receptor‐2 antagonist C781 limits allergen‐induced airway hyperresponsiveness and inflammation	55
Airway delivery of Streptococcus salivarius is sufficient to induce experimental pulmonary hypertension in rats	55
Issue Information	54
Intravenous recombinant cerebellin 1 treatment restores signalling by spinal glutamate delta 1 receptors and mitigates chronic pain	53
Translational PK/PD and model‐informed development of JNJ‐67842125, a F_ab reversal agent for JNJ‐64179375, a long‐acting thrombin inhibitor	53
Identification of a human blood biomarker of pharmacological 11β‐hydroxysteroid dehydrogenase 1 inhibition	51
Targeting mitochondrial proteases for therapy of acute myeloid leukaemia	50
Targeting cluster of differentiation 26 / dipeptidyl peptidase 4 (CD26/DPP4) in organ fibrosis	49